IGF-1 LR3

Ergogenic / Growth

Muscle growth and recovery positioning

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Growth factor analog
Primary mechanism: IGF-1 receptor activation
Primary market use: Sports/body composition

Pharmacology

Molecular weight (Da): ~9118
Oral bioavailability: N/A
Half-life: ~20-30 h
Route tags: Route-dependent / verify
Evidence level: Research
Clinical status: Experimental
Value-for-money score: 5 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Structural changes depend on training and tissue response

Sources

https://pubmed.ncbi.nlm.nih.gov/